SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030795
Filing Date
2019-08-08
Accepted
2019-08-08 16:16:24
Documents
62
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q clsd-10q_20190630.htm 10-Q 1366799
2 EX-10.1 clsd-ex101_131.htm EX-10.1 52241
3 EX-10.2 clsd-ex102_132.htm EX-10.2 38829
4 EX-10.3 clsd-ex103_296.htm EX-10.3 13396
5 EX-31.1 clsd-ex311_6.htm EX-31.1 16717
6 EX-31.2 clsd-ex312_8.htm EX-31.2 16693
7 EX-32.1 clsd-ex321_7.htm EX-32.1 9020
  Complete submission text file 0001564590-19-030795.txt   5042448

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT clsd-20190630.xml EX-101.INS 965350
9 XBRL TAXONOMY EXTENSION SCHEMA clsd-20190630.xsd EX-101.SCH 42309
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clsd-20190630_cal.xml EX-101.CAL 46442
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clsd-20190630_def.xml EX-101.DEF 135996
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE clsd-20190630_lab.xml EX-101.LAB 346686
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clsd-20190630_pre.xml EX-101.PRE 252304
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 191009741
SIC: 2834 Pharmaceutical Preparations